nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abdominal aortic aneurysm:
|
Criado, Frank J |
|
2002 |
194 |
1S1 |
p. S88-S97 10 p. |
artikel |
2 |
Abdominal aortic endografting:
|
Greenberg, Roy K |
|
2002 |
194 |
1S1 |
p. S79-S87 9 p. |
artikel |
3 |
Carotid endarterectomy: the “gold standard” in the endovascular era 1 1 No competing interests declared.
|
Perler, Bruce A |
|
2002 |
194 |
1S1 |
p. S2-S8 7 p. |
artikel |
4 |
Causes and outcomes of open conversion and aneurysm rupture after endovascular abdominal aortic aneurysm repair: can type ii endoleaks be dangerous? 1 1 No competing interests declared.
|
Buth, Jacob |
|
2002 |
194 |
1S1 |
p. S98-S102 5 p. |
artikel |
5 |
Combination therapy in peripheral vascular disease:
|
Shlansky-Goldberg, Richard |
|
2002 |
194 |
1S1 |
p. S103-S113 11 p. |
artikel |
6 |
Endovascular treatment of acute stroke
|
Ringer, Andrew J |
|
2002 |
194 |
1S1 |
p. S15-S21 7 p. |
artikel |
7 |
Infrainguinal vein bypass graft surveillance: how to do it, when to intervene, and is it cost-effective? 1 1 No competing interests declared.
|
Bandyk, Dennis F |
|
2002 |
194 |
1S1 |
p. S40-S52 13 p. |
artikel |
8 |
Patient selection for endovascular abdominal aortic aneurysm repair
|
Green, Richard M |
|
2002 |
194 |
1S1 |
p. S67-S73 7 p. |
artikel |
9 |
Percutaneous transluminal angioplasty and stenting in the treatment of chronic mesenteric ischemia: results and longterm followup 1 1 Dr Matsumoto owns stock in Johnson and Johnson, and Boston Scientific.
|
Matsumoto, Alan H |
|
2002 |
194 |
1S1 |
p. S22-S31 10 p. |
artikel |
10 |
Percutaneous ultrasound-guided thrombin injection for the treatment of pseudoaneurysms 1 1 No competing interests declared.
|
Powell, Alex |
|
2002 |
194 |
1S1 |
p. S53-S57 5 p. |
artikel |
11 |
Presentations from the international symposium on endovascular therapy (iset)
|
Ouriel, Kenneth |
|
2002 |
194 |
1S1 |
p. S1- 1 p. |
artikel |
12 |
Ten-year experience with endovascular therapy in aortic aneurysms 1 1 No competing interests declared.
|
Parodi, Juan C |
|
2002 |
194 |
1S1 |
p. S58-S66 9 p. |
artikel |
13 |
The evolution of Z stent–based stent-grafts for endovascular aneurysm repair:
|
Resch, Timothy |
|
2002 |
194 |
1S1 |
p. S74-S78 5 p. |
artikel |
14 |
Thrombolytic therapy for acute arterial occlusion 1 1 Dr. Ouriel is a consultant for Abbott Laboratories. He receives research support from Centocor and Genentech.
|
Ouriel, Kenneth |
|
2002 |
194 |
1S1 |
p. S32-S39 8 p. |
artikel |
15 |
Update on the carotid revascularization endarterectomy versus stent trial (CREST) protocol 1 1 No competing interests declared.
|
Hobson II, Robert W |
|
2002 |
194 |
1S1 |
p. S9-S14 6 p. |
artikel |